Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
HLN · NYSE · United States · Perfumes, Cosmetics & Other Toilet Preparations
In shortHaleon plc is profitable, generates cash and carries moderate debt, with revenue stable (−1.8% last year).
Financial health
Solid
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 21.9% | 90/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 15.1% | 80/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 10.2% | 51/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 7.5% | 50/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 0.92× | 10/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.52× | 82/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 2.63× | 39/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 7.09× | 53/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 4.27 | 81/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 21.0% | 100/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 1.39× | 100/100 |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 5 of 5 | 100/100 |
|---|---|---|
| Years of revenue decline (last 5) | 3 of 5 | 0/100 |
| Revenue growth volatility | 7.0% | 85/100 |
| Operating margin volatility | 2.1% | 90/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 0.5% | 20/100 |
|---|---|---|
| EPS growth, 3-year average | 17.2% | 100/100 |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
1 older year available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
GBP millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 9,545 | 10,858 | 11,302 | 11,233 | 11,030 |
| Cost of revenue | 3,595 | 4,281 | 4,555 | 4,409 | 3,950 |
| Gross profit | 5,950 | 6,577 | 6,747 | 6,824 | 7,080 |
| Research & development | 257 | 300 | 311 | 298 | 316 |
| Selling, general & admin | 4,086 | 4,483 | 4,413 | 4,452 | 4,364 |
| Operating income | 1,638 | 1,825 | 1,996 | 2,206 | 2,412 |
| Interest expense | 19 | 258 | 402 | 384 | 340 |
| Pre-tax income | 1,636 | 1,618 | 1,628 | 1,910 | 2,152 |
| Income tax | 197 | 499 | 517 | 435 | 472 |
| Net income | 1,390 | 1,060 | 1,049 | 1,442 | 1,667 |
| Diluted EPS | £0.15 | £0.12 | £0.11 | £0.16 | £0.19 |
| Diluted shares (millions) | 9,235 | 9,239 | 9,263 | 9,175 | 9,026 |
1 older year available with the 10-year history. Essential plan, from €8.25/month →
4.27 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
8/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Dec 31, 2025 · Data updated Mar 13, 2026